Literature DB >> 33190287

Ending rheumatic heart disease in Australia: the evidence for a new approach.

Rosemary Wyber1,2, Katharine Noonan2, Catherine Halkon2, Stephanie Enkel2, Jeffrey Cannon2, Emma Haynes3, Alice G Mitchell4, Dawn C Bessarab3, Judith M Katzenellenbogen2,3, Daniela Bond-Smith3, Rebecca Seth2,3, Heather D'Antoine4, Anna P Ralph4, Asha C Bowen2,5, Alex Brown6,7, Jonathan R Carapetis2,5.   

Abstract

■The RHD Endgame Strategy: the blueprint to eliminate rheumatic heart disease in Australia by 2031 (the Endgame Strategy) is the blueprint to eliminate rheumatic heart disease (RHD) in Australia by 2031. Aboriginal and Torres Strait Islander people live with one of the highest per capita burdens of RHD in the world. ■The Endgame Strategy synthesises information compiled across the 5-year lifespan of the End Rheumatic Heart Disease Centre of Research Excellence (END RHD CRE). Data and results from priority research projects across several disciplines of research complemented literature reviews, systematic reviews and narrative reviews. Further, the experiences of those working in acute rheumatic fever (ARF) and RHD control and those living with RHD to provide the technical evidence for eliminating RHD in Australia were included. ■The lived experience of RHD is a critical factor in health outcomes. All future strategies to address ARF and RHD must prioritise Aboriginal and Torres Strait Islander people's knowledge, perspectives and experiences and develop co-designed approaches to RHD elimination. The environmental, economic, social and political context of RHD in Australia is inexorably linked to ending the disease. ■Statistical modelling undertaken in 2019 looked at the economic and health impacts of implementing an indicative strategy to eliminate RHD by 2031. Beginning in 2019, the strategy would include: reducing household crowding, improving hygiene infrastructure, strengthening primary health care and improving secondary prophylaxis. It was estimated that the strategy would prevent 663 deaths and save the health care system $188 million. ■The Endgame Strategy provides the evidence for a new approach to RHD elimination. It proposes an implementation framework of five priority action areas. These focus on strategies to prevent new cases of ARF and RHD early in the causal pathway from Streptococcus pyogenes exposure to ARF, and strategies that address the critical systems and structural changes needed to support a comprehensive RHD elimination strategy. & 2020 AMPCo Pty Ltd.

Entities:  

Keywords:  Indigenous health; Rheumatic heart disease; Streptococcus

Year:  2020        PMID: 33190287     DOI: 10.5694/mja2.50853

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  11 in total

1.  Long-term outcomes following rheumatic heart disease diagnosis in Australia.

Authors:  Ingrid Stacey; Joseph Hung; Jeff Cannon; Rebecca J Seth; Bo Remenyi; Daniela Bond-Smith; Kalinda Griffiths; Frank Sanfilippo; Jonathan Carapetis; Kevin Murray; Judith M Katzenellenbogen
Journal:  Eur Heart J Open       Date:  2021-11-09

Review 2.  Valvular Heart Disease Epidemiology.

Authors:  John Sukumar Aluru; Adam Barsouk; Kalyan Saginala; Prashanth Rawla; Alexander Barsouk
Journal:  Med Sci (Basel)       Date:  2022-06-15

3.  The use of cardiac valve procedures for rheumatic heart disease in Australia; a cross-sectional study 2002-2017.

Authors:  Pamela J Bradshaw; Hideo Tohira; James Marangou; Mark Newman; Bo Reményi; Vicki Wade; Christopher Reid; Judith M Katzenellenbogen
Journal:  Ann Med Surg (Lond)       Date:  2020-11-25

4.  Caring for Pregnant Women with Rheumatic Heart Disease: A Qualitative Study of Health Service Provider Perspectives.

Authors:  Geraldine Vaughan; Angela Dawson; Michael Peek; Jonathan Carapetis; Vicki Wade; Elizabeth Sullivan
Journal:  Glob Heart       Date:  2021-12-22

Review 5.  Scabies in remote Aboriginal and Torres Strait Islander populations in Australia: A narrative review.

Authors:  Prudence Gramp; Dallas Gramp
Journal:  PLoS Negl Trop Dis       Date:  2021-09-30

Review 6.  Rheumatic Heart Disease in Pregnancy: New Strategies for an Old Disease?

Authors:  Geraldine Vaughan; Angela Dawson; Michael Peek; Karen Sliwa; Jonathan Carapetis; Vicki Wade; Elizabeth Sullivan
Journal:  Glob Heart       Date:  2021-12-20

7.  Evaluation of an ARF diagnosis calculator: a survey and content analysis.

Authors:  Elizabeth Fisher; Christian James; Diana Mosca; Bart J Currie; Anna P Ralph
Journal:  BMC Med Inform Decis Mak       Date:  2022-03-26       Impact factor: 2.796

Review 8.  Recent Advances in the Rheumatic Fever and Rheumatic Heart Disease Continuum.

Authors:  Joselyn Rwebembera; Bruno Ramos Nascimento; Neema W Minja; Sarah de Loizaga; Twalib Aliku; Luiza Pereira Afonso Dos Santos; Bruno Fernandes Galdino; Luiza Silame Corte; Vicente Rezende Silva; Andrew Young Chang; Walderez Ornelas Dutra; Maria Carmo Pereira Nunes; Andrea Zawacki Beaton
Journal:  Pathogens       Date:  2022-01-28

9.  Missing Piece Study protocol: prospective surveillance to determine the epidemiology of group A streptococcal pharyngitis and impetigo in remote Western Australia.

Authors:  Dylan D Barth; Marianne J Mullane; Claudia Sampson; Coco Chou; Janessa Pickering; Mark P Nicol; Mark R Davies; Jonathan Carapetis; Asha C Bowen
Journal:  BMJ Open       Date:  2022-04-06       Impact factor: 2.692

Review 10.  Improving primary prevention of acute rheumatic fever in Australia: consensus primary care priorities identified through an eDelphi process.

Authors:  Rosemary Wyber; Catalina Lizama; Vicki Wade; Glenn Pearson; Jonathan Carapetis; Anna P Ralph; Asha C Bowen; David Peiris
Journal:  BMJ Open       Date:  2022-03-10       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.